Souhaitez-vous accéder aux communiqués récents ?

Transaction Positions JUNS at the Forefront of Next-Generation MDMA-Based Therapeutics Following President Trump's April 18, 2026, Executive Order Accelerating Psychedelic Medicine JUPITER, FL, May ...

Austin, TX, USA, May 18, 2026 (GLOBE NEWSWIRE) -- Healthcare Foresights has published a new research report titled “Orthopedic Soft Tissue Repair Market Size, Trends and Insights By Product Type...

The analysis explores how intelligent packaging formats are reshaping pharmaceutical operations from early-stage product design to final distribution.

NEW YORK, April 17, 2026 (GLOBE NEWSWIRE) -- The U.S. Chamber of Commerce conducted a nationwide media tour featuring Brad Watts, Senior Vice President of the Global Innovation Policy Center, to...

Researchers at IOB developed targeted delivery of healthy mitochondria to diseased cells, opening new paths for treating mitochondrial disorders.

Advanced materials science sits at the intersection of biology, chemistry, and engineering. $KBLB, $LHX, $HXL, $AVNT, $ASPN

Vancouver, Canada, April 14, 2026 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on the discovery and...

Rapid expansion in clinical applications, rising demand for genomic diagnostics, and increased investment in CRISPR-based therapeutics are fueling demand.

ROCKAWAY, N.J., March 30, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced the issuance of two new U.S....

The global market for neuroprotective agents was valued at $41.2 billion in 2024 and is expected to reach $60.9 billion by the end of 2030.